Mieke L. Van Schaik - Publications

Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm.

Journal: Nature reviews. Nephrology

Published: July 02, 2026

Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report.

Journal: Lupus science & medicine

Published: October 17, 2024

Differences in Dynamics of Specific Antinuclear Antibodies and Their Susceptibility to B Cell-Targeting Treatment in Patients With Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 21, 2024

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy.

Journal: Kidney international reports

Published: January 13, 2024

Long-term renal and cardiovascular risks of tacrolimus in patients with lupus nephritis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 01, 2023

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.

Journal: Trials

Published: April 21, 2022

Two isothermal challenges yield comparable physiological and subjective responses.

Journal: European journal of applied physiology

Published: July 18, 2019

Feasibility of a quantitative polymerase chain reaction assay for diagnosing pneumococcal pneumonia using oropharyngeal swabs.

Journal: Molecular biology reports

Published: June 25, 2018

Fever, abdominal erythema and subcutaneous emphysema.

Journal: The Netherlands journal of medicine

Published: January 31, 2018